Litcius/Paper detail

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant

Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, Piyanate Sunyakumthorn, Sathit Pichyangkul, Pornnarin Taepavarapruk, Wanlapa Praserthsee, Suchinda Malaivijitnond, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanjana Srisutthisamphan, Anan Jongkaewwattana, Mark A. Tomai, Christopher B. Fox, Suthira Taychakhoonavudh

2023Vaccine17 citationsDOIOpen Access PDF

Topics & Concepts

ImmunogenicityAdjuvantNeutralizing antibodyMedicineVirologyImmunizationImmune systemVaccinationAntibodyImmunologyRecombinant DNAAlumBiologyChemistryOrganic chemistryBiochemistryGeneTransgenic Plants and ApplicationsSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant | Litcius